Potential of Bioactive Compound from Elephantopus scaber Linn. LEAF as Anti-Cancer Through in Silico Test
Journal: Journal of Medicinal and Chemical Sciences (Vol.6, No. 8)Publication Date: 2023-08-01
Authors : Yuliani Yuliani; Firas Khaleyla; Dwi Anggorowati Rahayu;
Page : 1773-1782
Keywords : bioactive compound; Elephantopus scaber; Anticancer; In Silico;
Abstract
Elephantopus scaber contains secondary metabolites, such as triterpenoids, sesquiterpene lactones, elephantopin, epifriedelinol, lupeol, stiqmasterol, lupeolacetate, deoxyelephantopin, and isodeoxyelephantopin. The plant can be used for medicinal purposes to treat cancer, diabetes, leukemia, viral and bacterial infections, bronchitis, and hepatitis. Therefore, this research aims to isolate and identify the bio-active compounds in Elephantopus scaber leaf extract and to analyze the effectiveness of binding the constituents through molecular docking against NF-kB. The method used included two stages. The first stage was extraction, fractionation, isolation, and identification, while the second was the in silico test, including the sample preparation, molecular docking, and visualization. The results showed that 10 bioactive compounds had the potential as anti-cancer compounds. Based on the binding affinity of the molecular docking, the compounds with the lowest values were b-amyrin (-8.0 kcal/mal), a-amyrin (-6.9 kcal/mol), and Cycloartane-3.beta 25-diol (-6.9 kcal/mol). Furthermore, the three compounds have potential as anti-cancer agents.
Other Latest Articles
- Oral Findings, Salivary Bicarbonate, and Phosphate Levels in Patients with Gastroesophageal Reflux Disease
- Isolation and Characterization of Hyperoside-Flavanoidal Glycoside from Rourea Minor for its Anti-Hyperglycemic Activity Potential: An In Vitro Study
- Expression of MicroRNA-155-5p in Chronic Kidney Disease as a Potential Marker of Cardiovascular Complications
- Impact of High Blood Pressure (HBP) on Health among Indian Stockholders
- Synthesis, Characterisation, and Biological and Computational Studies of Novel Schiff Bases from Heterocyclic Molecules
Last modified: 2023-04-06 17:43:01